The research aims to characterize changes in ovarian and pituitary hormones associated with the development of ovarian follicular waves during the human menstrual cycle.
Age range
18 Years – 40 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Antral follicle diameter
Timeframe: One menstrual cycle (21-35 days) per volunteer
Antral follicle count
Timeframe: One menstrual cycle (21-35 days) per volunteer
Follicle stimulating hormone (FSH) serum level
Timeframe: One menstrual cycle (21-35 days) per volunteer
Luteinizing hormone (LH) serum level
Timeframe: One menstrual cycle (21-35 days) per volunteer
Estradiol serum level
Timeframe: One menstrual cycle (21-35 days) per volunteer
Progesterone serum level
Timeframe: One menstrual cycle (21-35 days) per volunteer
Anti-mullerian hormone (AMH) serum level
Timeframe: One menstrual cycle (21-35 days) per volunteer
Inhibin A serum level
Timeframe: One menstrual cycle (21-35 days) per volunteer
Inhibin B serum level
Timeframe: One menstrual cycle (21-35 days) per volunteer